ABC News Live
124

By the Numbers: Pfizer's $15 billion payday

Drugmaker Pfizer expects $15 billion in revenue from its COVID-19 vaccine in 2021 and said it can produce 2 billion doses this year, including 200 million doses for the U.S.

Business

Top Stories

Election Zone 2020

Features

Politics

Health

Entertainment